PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16007152-1	2005	The antiapoptotic Bcl-2-family proteins, Bcl-2 and Bcl-xL, are recognized phototargets of photodynamic therapy (PDT) with the mitochondrion-targeting phthalocyanine photosensitizer Pc 4.	phthalocyanine	150-164	BCL2 apoptosis regulator	Homo sapiens	18-23	
16007152-1	2005	The antiapoptotic Bcl-2-family proteins, Bcl-2 and Bcl-xL, are recognized phototargets of photodynamic therapy (PDT) with the mitochondrion-targeting phthalocyanine photosensitizer Pc 4.	phthalocyanine	150-164	BCL2 apoptosis regulator	Homo sapiens	41-46	
12929741-0	2003	Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy.	phthalocyanine	94-108	BCL2 apoptosis regulator	Homo sapiens	45-50	
12929741-1	2003	We have reported that photodynamic therapy (PDT) using the photosensitizer phthalocyanine (Pc) 4 and red light damages the antiapoptotic protein Bcl-2.	phthalocyanine	75-89	BCL2 apoptosis regulator	Homo sapiens	145-150	
11423992-0	2001	Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4.	phthalocyanine	88-102	BCL2 apoptosis regulator	Homo sapiens	33-38